Starry-Med is a fast-growing chemical CDMO enterprise. Since established in 2013, driven by technological innovation and committed to serving customers, Starry-Med has actively cooperated with customers around the world, design and manufactures all kinds of molecules.

Starry-Med is committed to building the world's leading chemical customization platform. Relying on advanced R&D technology, excellent production capacity, and perfect quality management/EHS management system, we provide global customers with core services ranging from small-scale and pilot scale-up to commercial production. The product line includes all kinds of pharmaceutical intermediates, electronic chemicals, new cosmetics, and new material intermediates.   

Starry-Med  R&D Center is located in Degan Technology Park, Jiangjin District, Chongqing City. It has a professional synthesis R&D laboratory, an analysis laboratory, 3 chemical production workshops and 2 professional chemical warehouses. The park is equipped with steam, sewage treatment equipment and three wastes treatment. Various specifications and models of power equipment, reaction instruments, analytical instruments and supporting equipment facilities are complete, and it has the full-process chemical customization production capacity from gram-level research and development, kilo-level pilot test, to large-scale ton-level production. The Shandong Weifang production base covers an area of about 60 acres and is mainly responsible for the commercial production of products.

More than 90% of our new pharmaceutical intermediates, new material intermediates and other products are exported to India and European and American countries. including Corden Pharma, Samsung, LG, Takeda, Lundbeck, Novartis, and BASF.